Siga Technologies SIGA
NASDAQ SIGA
$3.09 -0.11 (-3.44%)
As of: Sep 9, 2026 · 3:59 PM EDT

Siga Technologies (SIGA) Liabilities and Shareholders Equity (2010 - 2025)

Siga Technologies' (SIGA) quarterly Liabilities and Shareholders Equity came in at $219.5 million in Q4 2025, down 10.18% on a YoY basis from $244.3 million in Q4 2024, and down 5.24% quarter-over-quarter from $231.6 million in Q3 2025.

Analysis

Siga Technologies (SIGA) Liabilities and Shareholders Equity (2010 - 2025) Analysis & Trends

Siga Technologies (SIGA) has reported Liabilities and Shareholders Equity for 16 consecutive years, with $219.5 million the latest figure, recorded in Q4 2025.

  • For the quarter ending Q4 2025, Liabilities and Shareholders Equity fell 10.18% year-over-year to $219.5 million; the trailing twelve-month figure through Dec 2025 stood at $933.5 million (up 6.62% YoY), and the FY2025 full-year result was $219.5 million, down 10.18% from the prior year.
  • Liabilities and Shareholders Equity eased to $219.5 million in Q4 2025 per SIGA's latest filing, from $231.6 million in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $254.4 million in Q4 2023 and bottomed at $133.7 million in Q2 2021.
  • Historically, Liabilities and Shareholders Equity has averaged $195.9 million across 5 years, with a median of $195.2 million in 2022.
  • The sharpest annual moves came in 2022 and 2023: Liabilities and Shareholders Equity surged 50.65% in 2022, then retreated 22.45% in 2023.
  • Over 5 years, Liabilities and Shareholders Equity stood at $214.7 million in 2021, then retreated by 9.17% to $195.0 million in 2022, then jumped by 30.41% to $254.4 million in 2023, then declined by 3.94% to $244.3 million in 2024, then retreated by 10.18% to $219.5 million in 2025.
  • According to Business Quant data, Liabilities and Shareholders Equity over the past three periods registered $219.5 million, $231.6 million, and $235.3 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Johnson & Johnson 643.26 Bn 622.50 Bn 17.26 Bn 201.06 Bn
2 AbbVie 443.31 Bn 436.74 Bn 12.70 Bn 135.12 Bn
3 Merck 364.74 Bn 357.60 Bn 12.21 Bn 129.80 Bn
4 Novartis Ag 266.46 Bn 258.77 Bn 11.24 Bn 122.03 Bn
5 Pfizer 158.57 Bn 146.88 Bn 10.94 Bn 201.13 Bn
6 Sanofi 52.33 Bn 44.95 Bn 10.79 Bn 150.01 Bn
7 Revolution Medicines 43.79 Bn 43.79 Bn - 4.32 Bn
8 Incyte 25.23 Bn 20.69 Bn 1.57 Bn 7.87 Bn
9 United Therapeutics 21.67 Bn 19.01 Bn 683.80 Mn 7.22 Bn
10 Siga Technologies 220.19 Mn 65.22 Mn - 219.47 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 219.47 Mn
Sep 30, 2025 231.60 Mn
Jun 30, 2025 235.33 Mn
Mar 31, 2025 247.07 Mn
Dec 31, 2024 244.34 Mn
Sep 30, 2024 195.35 Mn
Jun 30, 2024 192.66 Mn
Mar 31, 2024 243.15 Mn
Dec 31, 2023 254.35 Mn
Sep 30, 2023 158.38 Mn
Jun 30, 2023 146.51 Mn
Mar 31, 2023 183.92 Mn
Dec 31, 2022 195.04 Mn
Sep 30, 2022 204.22 Mn
Jun 30, 2022 159.94 Mn
Mar 31, 2022 184.55 Mn
Dec 31, 2021 214.73 Mn
Sep 30, 2021 135.56 Mn
Jun 30, 2021 133.69 Mn
Mar 31, 2021 138.77 Mn